Premier Alternatives

Avenacy

Schaumburg, IL · Founded 2023 · Privately Held (backing)

Operator of a pharmaceutical firm intended to make critical injectable medications. Avenacy is based in Schaumburg, IL and was founded in 2023. It was valued at $40 million at its early-stage round in Dec 2024, the last priced event on record. It has raised $26 million across 1 recorded round; the latest was a $26 million early-stage round in Nov 2024.

PMV mark · valuation
$40.0M
Oct 2026
Priced at
its early-stage round
Dec 2024
Total raised
$26.0M
Last round
Early Stage VC
Nov 2024
How much has Avenacy raised?
$26.0Macross 1 recorded rounds · Nov 2024 – Nov 2024

Most recently, Avenacy raised $26.0M in its Early Stage VC (Nov 2024).

Free account
More of Avenacy with a free account
  • ·Watch Avenacy: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Avenacy round by round

1 rounds
Nov 2024Early Stage VC$26.0MSEC filing▮
2 investors participated

How much has Avenacy raised?

Avenacy has raised $26 million across 1 recorded round since 2024. The largest was a $26 million early-stage round in Nov 2024.

Avenacy has filed 1 Form D with the SEC, most recently in Nov 2024 ($26 million sold to 2 investors).

Avenacy investors

1 investor is on record for Avenacy, including NantWorks. The early-stage round in Nov 2024 drew 2 investors.

For fundraisers
Raising for a company like Avenacy?

1 investors have backed Avenacy.

See all 1 investors →

Frequently asked about Avenacy

How much has Avenacy raised?
Avenacy has raised $26.0M in total across 1 recorded funding rounds.
When was Avenacy's last funding round?
Avenacy's most recent recorded round was Early Stage VC in Nov 2024, raising $26.0M.